Tumor Staging and PD-L1 Assessment
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Nanjing Medical University
Other organizations : Simcere Pharmaceutical (China)
Variable analysis
- Surgical specimens staged according to the criteria of the American Joint Committee on Cancer (eighth edition)
- Routine H&E staining of primary tumors assessed for pathological regression according to the criteria of the College of American Pathologists/National Comprehensive Cancer Network
- Programmed death ligand 1 (PD-L1) expression determined using the 22C3 pharmDx kit (Dako North America, Carpinteria, California, USA)
- Pathological regression of primary tumors
- Programmed death ligand 1 (PD-L1) expression
- Surgical specimens staged independently by two expert oncopathologists
- Scanned slides containing lymph node slices identified, reviewed, and classified as described previously
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!